Skip to main content
Loading

Breakpoint Therapeutics GmbH

October 18, 2023
Franciscan C
Oncology
Breakpoint Therapeutics GmbH is a pre-clinical stage company dedicated to the discovery and development of novel oncology drugs that target the DNA damage response (DDR) in cancer cells.
Speakers
Daniel Speidel, Managing Director - Breakpoint Therapeutics GmbH